The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
TDP-43 Mutations in Familial and Sporadic Amyotrophic Lateral Sclerosis
Open accessAbstract
Amyotrophic lateral sclerosis (ALS) is a fatal motor neuron disorder characterized pathologically by ubiquitinated TAR DNA binding protein (TDP-43) inclusions. The function of TDP-43 in the nervous system is uncertain, and a mechanistic role in neurodegeneration remains speculative. We identified neighboring mutations in a highly conserved region of TARDBP in sporadic and familial ALS cases. TARDBPM337V segregated with disease within one kindred and a genome-wide scan confirmed that linkage was restricted to chromosome 1p36, which contains the TARDBP locus. Mutant forms of TDP-43 fragmented in vitro more readily than wild type and, in vivo, caused neural apoptosis and developmental delay in the chick embryo. Our evidence suggests a pathophysiological link between TDP-43 and ALS.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Mutations in TARDBP, which encodes the transactive response DNA binding protein 43 kDa (TDP-43), are the third most common cause of familial autosomal dominant ALS and account for rare cases of sporadic ALS [290–293].”
From Autophagy and ALS: mechanistic insights and therapeutic implications (2022) · cites this paper as [291]
In the citing paper
“while mutations in TARDBP (encoding TAR DNA- binding protein 43 [TDP43])306 and FUS (encoding the fused in sarcoma protein) have a lower frequency (<5%).307”
From Microglia in neurodegenerative diseases: mechanism and potential therapeutic targets (2023) · cites this paper as [306]
In the citing paper
“emphasizing that microglia in the late stage accelerate disease progression.”
From Microglia in neurodegenerative diseases: mechanism and potential therapeutic targets (2023) · cites this paper as [306]
In the citing paper
“and mutations in TARDBP, the gene encoding TDP-43, have been identified in patients with ALS or FTD,306,333 indicating a mechanistic link between TDP-43 and ALS/FTD and also suggesting a common underlying mechanism”
From Microglia in neurodegenerative diseases: mechanism and potential therapeutic targets (2023) · cites this paper as [306]
In the citing paper
“Reduced mutant levels in microglia did not have much effect on early disease progression, but substantially slowed it later on,306”
From Microglia in neurodegenerative diseases: mechanism and potential therapeutic targets (2023) · cites this paper as [306]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Rosen, D. R., Siddique, T., Patterson, D., Figlewicz, D. A., Sapp, P., Hentati, A., Donaldson, D., Goto, J., O'Regan, J. P., Deng, H.-X., et al. (1993) · Nature · doi:10.1038/362059a0 · Cited by 7,062
Ubiquitinated TDP-43 in Frontotemporal Lobar Degeneration and Amyotrophic Lateral Sclerosis
Neumann, M., Sampathu, D. M., Kwong, L. K., Truax, A. C., Micsenyi, M. C., Chou, T. T., Bruce, J., Schuck, T., Grossman, M., Clark, C. M., et al. (2006) · Science · doi:10.1126/science.1134108 · Cited by 6,576
El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis
Brooks, B. R., Miller, R. G., Swash, M., & Munsat, T. L. (2000) · Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders · doi:10.1080/146608200300079536 · Cited by 5,433
Motor Neuron Degeneration in Mice that Express a Human Cu,Zn Superoxide Dismutase Mutation
Gurney, M. E., Pu, H., Chiu, A. Y., Dal Canto, M. C., Polchow, C. Y., Alexander, D. D., Caliendo, J., Hentati, A., Kwon, Y. W., Deng, H.-X., et al. (1994) · Science · doi:10.1126/science.8209258 · Cited by 4,143
Arai, T., Hasegawa, M., Akiyama, H., Ikeda, K., Nonaka, T., Mori, H., Mann, D., Tsuchiya, K., Yoshida, M., Hashizume, Y., et al. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.10.093 · Cited by 2,732
TDP‐43 immunoreactivity in hippocampal sclerosis and Alzheimer's disease
Amador‐Ortiz, C., Lin, W., Ahmed, Z., Personett, D., Davies, P., Duara, R., Graff‐Radford, N. R., Hutton, M. L., & Dickson, D. W. (2007) · Annals of Neurology · doi:10.1002/ana.21154 · Cited by 916
A gene encoding a putative GTPase regulator is mutated in familial amyotrophic lateral sclerosis 2
Hadano, S., Hand, C. K., Osuga, H., Yanagisawa, Y., Otomo, A., Devon, R. S., Miyamoto, N., Showguchi-Miyata, J., Okada, Y., Singaraja, R. R., et al. (2001) · Nature Genetics · doi:10.1038/ng1001-166 · Cited by 676
Multiple roles of TDP-43 in gene expression, splicing regulation, and human disease
Buratti, E. (2007) · Frontiers in bioscience · doi:10.2741/2727 · Cited by 493
Self-citationTDP-43 Binds Heterogeneous Nuclear Ribonucleoprotein A/B through Its C-terminal Tail
Buratti, E., Brindisi, A., Giombi, M., Tisminetzky, S. G., Ayala, Y. M., & Baralle, F. E. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m505557200 · Cited by 474
Self-citationCo-morbidity of TDP-43 proteinopathy in Lewy body related diseases
Nakashima-Yasuda, H., Uryu, K., Robinson, J., Xie, S. X., Hurtig, H., Duda, J. E., Arnold, S. E., Siderowf, A., Grossman, M., Leverenz, J. B., et al. (2007) · Acta Neuropathologica · doi:10.1007/s00401-007-0261-2 · Cited by 468
Flagged first, then by citations
Cited by
Sorted by citations
Items 601–700 of 1,011
Amyotrophic Lateral Sclerosis and Autophagy: Dysfunction and Therapeutic Targeting
Amin, A., Perera, N. D., Beart, P. M., Turner, B. J., & Shabanpoor, F. (2020) · Cells · doi:10.3390/cells9112413 · Cited by 103
Aggregation of Disordered Proteins Associated with Neurodegeneration
Tsoi, P. S., Quan, M. D., Ferreon, J. C., & Ferreon, A. C. M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24043380 · Cited by 103
Moving beyond amyloid and tau to capture the biological heterogeneity of Alzheimer’s disease
Young‐Pearse, T. L., Lee, H., Hsieh, Y., Chou, V., & Selkoe, D. J. (2023) · Trends in Neurosciences · doi:10.1016/j.tins.2023.03.005 · Cited by 104
Chapter 1 The Molecular Links Between TDP‐43 Dysfunction and Neurodegeneration
Buratti, E., & Baralle, F. E. (2009) · Advances in genetics · doi:10.1016/s0065-2660(09)66001-6 · Cited by 102
Self-citationTDP-43 Depletion Induces Neuronal Cell Damage through Dysregulation of Rho Family GTPases
Iguchi, Y., Katsuno, M., Niwa, J.-I., Yamada, S.-I., Sone, J., Waza, M., Adachi, H., Tanaka, F., Nagata, K., Arimura, N., et al. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.012195 · Cited by 102
Neuronal intermediate filaments and neurodegenerative disorders
Perrot, R., & Eyer, J. (2009) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2009.06.004 · Cited by 102
Biomarker-based dissection of neurodegenerative diseases
Olsson, B., Zetterberg, H., Hampel, H. J., & Blennow, K. (2011) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2011.04.006 · Cited by 102
Standley, J. M. (1998) · PubMed · Cited by 102
Autophagy receptor defects and ALS-FTLD
Majcher, V., Goode, A., James, V. H., & Layfield, R. (2015) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2015.01.002 · Cited by 101
Cascella, R., Capitini, C., Fani, G., Dobson, C. M., Cecchi, C., & Chiti, F. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.737726 · Cited by 101
Heteromeric amyloid filaments of ANXA11 and TDP-43 in FTLD-TDP type C
Arseni, D., Nonaka, T., Jacobsen, M. H., Murzin, A. G., Cracco, L., Peak‐Chew, S., Garringer, H. J., Kawakami, I., Suzuki, H., Onaya, M., et al. (2024) · Nature · doi:10.1038/s41586-024-08024-5 · Cited by 101
TDP-43 regulates global translational yield by splicing of exon junction complex component SKAR
Fiesel, F. C., Weber, S. S., Supper, J., Zell, A., & Kahle, P. J. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkr1082 · Cited by 101
Pathogenic role of BECN1/Beclin 1 in the development of amyotrophic lateral sclerosis
Nassif, M., Valenzuela, V., Rojas-Rivera, D., Vidal, R., Matus, S., Castillo, K., Fuentealba, Y., Kroemer, G., Levine, B., & Hetz, C. (2014) · Autophagy · doi:10.4161/auto.28784 · Cited by 100
Implications of the prion-related Q/N domains in TDP-43 and FUS
Udan-Johns, M., & Baloh, R. H. (2011) · Prion · doi:10.4161/pri.5.1.14265 · Cited by 100
Probing Mechanisms That Underlie Human Neurodegenerative Diseases in Drosophila
Jaiswal, M., Sandoval, H., Zhang, K., Bayat, V., & Bellen, H. J. (2012) · Annual Review of Genetics · doi:10.1146/annurev-genet-110711-155456 · Cited by 100
TDP‐43 loss of function inhibits endosomal trafficking and alters trophic signaling in neurons
Schwenk, B. M., Hartmann, H., Serdaroglu, A., Schludi, M. H., Hornburg, D., Meissner, F., Orozco, D., Colombo, A. V., Tahirović, S., Michaelsen, M., et al. (2016) · The EMBO Journal · doi:10.15252/embj.201694221 · Cited by 100
Giacomelli, E., Vahsen, B. F., Calder, E. L., Xu, Y., Scaber, J., Gray, E., Dafinca, R., Talbot, K., & Studer, L. (2022) · Cell stem cell · doi:10.1016/j.stem.2021.12.008 · Cited by 100
Halliday, G. M., Bigio, E. H., Cairns, N. J., Neumann, M., Mackenzie, I. R., & Mann, D. M. A. (2012) · Acta Neuropathologica · doi:10.1007/s00401-012-1030-4 · Cited by 100
‘Costa da Morte’ ataxia is spinocerebellar ataxia 36: clinical and genetic characterization
García-Murias, M., Quintáns, B., Arias, M., Seixas, A. I., Cacheiro, P., Tarrı́o, R., Pardo, J., Millán, M. J., Rivas, S. A., Blanco, P., et al. (2012) · Brain · doi:10.1093/brain/aws069 · Cited by 100
Chiang, C.-H., Grauffel, C., Wu, L.-S., Kuo, P. H., Doudeva, L. G., Lim, C., Shen, C.-K. J., & Yuan, H. S. (2016) · Scientific Reports · doi:10.1038/srep21581 · Cited by 100
Smethurst, P., Sidle, K. C. L., & Hardy, J. (2014) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12206 · Cited by 99
Extensive cryptic splicing upon loss of RBM17 and TDP43 in neurodegeneration models
Tan, Q., Yalamanchili, H. K., Park, J., Maio, A. D., Lu, H., Wan, Y., White, J. J., Bondar, V. V., Sayegh, L. S., Liu, X., et al. (2016) · Human Molecular Genetics · doi:10.1093/hmg/ddw337 · Cited by 99
Amyotrophic lateral sclerosis: A 40-year personal perspective
Eisen, A. (2009) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2008.07.072 · Cited by 99
Martin, E., Cazenave, W., Cattaert, D., & Branchereau, P. (2013) · Neurobiology of Disease · doi:10.1016/j.nbd.2013.02.011 · Cited by 99
FUS‐Immunoreactive Intranuclear Inclusions in Neurodegenerative Disease
Woulfe, J., Gray, D. A., & Mackenzie, I. R. (2009) · Brain Pathology · doi:10.1111/j.1750-3639.2009.00337.x · Cited by 99
Genetics insight into the amyotrophic lateral sclerosis/frontotemporal dementia spectrum
Ji, A.-L., Zhang, X., Chen, W., & Huang, W. (2017) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2016-104271 · Cited by 99
Ichiyanagi, N., Fujimori, K., Yano, M., Ishihara-Fujisaki, C., Sone, T., Akiyama, T., Okada, Y., Akamatsu, W., Matsumoto, T., Ishikawa, M., et al. (2016) · Stem Cell Reports · doi:10.1016/j.stemcr.2016.02.011 · Cited by 98
Tremblay, C., St‐Amour, I., Schneider, J. A., Bennett, D. A., & Calon, F. (2011) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e31822c62cf · Cited by 98
Structural Plasticity of the Hippocampus in Neurodegenerative Diseases
Weerasinghe-Mudiyanselage, P. D. E., Ang, M. J., Kang, S., Kim, J., & Moon, C. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23063349 · Cited by 97
TDP-43-Based Animal Models of Neurodegeneration: New Insights into ALS Pathology and Pathophysiology
Wegorzewska, I., & Baloh, R. H. (2010) · Neurodegenerative Diseases · doi:10.1159/000321547 · Cited by 97
Jiang, L.-L., Zhao, J., Yin, X.-F., He, W.-T., Yang, H., Che, M., & Hu, H.-Y. (2016) · Scientific Reports · doi:10.1038/srep23928 · Cited by 97
Nuclear pore complexes — a doorway to neural injury in neurodegeneration
Coyne, A. N., & Rothstein, J. D. (2022) · Nature Reviews Neurology · doi:10.1038/s41582-022-00653-6 · Cited by 96
Traumatic injury induces stress granule formation and enhances motor dysfunctions in ALS/FTD models
Anderson, E. N., Gochenaur, L., Singh, A., Grant, R., Patel, K., Watkins, S., Wu, J. Y., & Pandey, U. B. (2018) · Human Molecular Genetics · doi:10.1093/hmg/ddy047 · Cited by 96
Calcium dysregulation links ALS defective proteins and motor neuron selective vulnerability
Leal, S. S., & Gomes, C. M. (2015) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2015.00225 · Cited by 96
Motor neuron involvement in multisystem proteinopathy
Benatar, M. G., Wuu, J., Fernandez, C., Weihl, C. C., Katzen, H., Steele, J., Oskarsson, B., & Taylor, J. P. (2013) · Neurology · doi:10.1212/wnl.0b013e3182929fc3 · Cited by 96
Markovinović, A., Cimbro, R., Ljutić, T., Križ, J., Rogelj, B., & Munitić, I. (2017) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2017.04.005 · Cited by 95
Self-citationDoes a loss of TDP-43 function cause neurodegeneration?
Xu, Z. (2012) · Molecular Neurodegeneration · doi:10.1186/1750-1326-7-27 · Cited by 95
Su, X., Broach, J. R., Connor, J. R., Gerhard, G. S., & Simmons, Z. (2014) · Muscle & Nerve · doi:10.1002/mus.24198 · Cited by 94
Amyotrophic lateral sclerosis: update and new developments
Perry, J. J. P., Pratt, A. J., & Getzoff (2012) · Degenerative Neurological and Neuromuscular Disease · doi:10.2147/dnnd.s19803 · Cited by 94
Gordon, D., Dafinca, R., Scaber, J., Alegre‐Abarrategui, J., Farrimond, L. E., Scott, C., Biggs, D., Kent, L., Oliver, P. L., Davies, B., et al. (2018) · Neurobiology of Disease · doi:10.1016/j.nbd.2018.09.024 · Cited by 94
Dysregulation of RNA-Binding Proteins in Amyotrophic Lateral Sclerosis
Xue, Y. C., Ng, C. S., Xiang, P., Liu, H., Zhang, K., Mohamud, Y., & Luo, H. (2020) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2020.00078 · Cited by 95
Shiga, A., Ishihara, T., Miyashita, A., Kuwabara, M., Kato, T., Watanabe, N., Yamahira, A., Kondo, C., Yokoseki, A., Takahashi, M., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0043120 · Cited by 94
TAR DNA-Binding Protein 43 Accumulation in Protein Aggregate Myopathies
Olivé, M., Janué, A., Moreno, D., Gámez, J., Torrejón-Escribano, B., & Ferrer, I. (2009) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e3181996d8f · Cited by 94
Wang, W., Arakawa, H., Wang, L., Okolo, O. B., Siedlak, S. L., Jiang, Y., Gao, J., Xie, F., Petersen, R. B., & Wang, X. (2017) · Molecular Therapy · doi:10.1016/j.ymthe.2016.10.013 · Cited by 94
Moisse, K., Mepham, J., Volkening, K., Welch, I., Hill, T., & Strong, M. J. (2009) · Brain Research · doi:10.1016/j.brainres.2009.07.023 · Cited by 93
Tau and TDP-43 proteinopathies: kindred pathologic cascades and genetic pleiotropy
Chornenkyy, Y., Fardo, D. W., & Nelson, P. T. (2019) · Laboratory Investigation · doi:10.1038/s41374-019-0196-y · Cited by 93
Shimonaka, S., Nonaka, T., Suzuki, G., Hisanaga, S.-I., & Hasegawa, M. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.713552 · Cited by 93
Kirby, J., Goodall, G., Smith, W., Highley, J. R., Masanzu, R., Hartley, J. A., Hibberd, R., Hollinger, H. C., Wharton, S. B., Morrison, K. E., et al. (2009) · Neurogenetics · doi:10.1007/s10048-009-0218-9 · Cited by 93
Bugallo, R., Marlin, E., Baltanás, A., Toledo, E., Ferrero, R., Vinueza‐Gavilanes, R., Larrea, L., Arrasate, M., & Aragón, T. (2020) · Cell Death and Disease · doi:10.1038/s41419-020-2601-2 · Cited by 93
Jinsheng, L., Duan, W., Guo, Y., Jiang, H. X., Li, Z., Huang, J., Hong, K., & Li, C. (2012) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2012.09.005 · Cited by 93
Herdewyn, S., Cirillo, C., Bosch, L. V. D., Robberecht, W., Berghe, P. V., & Damme, P. V. (2014) · Molecular Neurodegeneration · doi:10.1186/1750-1326-9-24 · Cited by 93
Cause or Effect: Misregulation of microRNA Pathways in Neurodegeneration
Gascon, E., & Gao, F.-B. (2012) · Frontiers in Neuroscience · doi:10.3389/fnins.2012.00048 · Cited by 69
Hedlund, E., Karlsson, M., Osborn, T. M., Ludwig, W. W., & Ole Isacson, A. (2010) · Brain · doi:10.1093/brain/awq167 · Cited by 93
Wang, J., Ho, W. Y., Lim, K., Feng, J., Tucker‐Kellogg, G., Nave, K., & Ling, S. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1809821115 · Cited by 94
Fragile X protein mitigates TDP-43 toxicity by remodeling RNA granules and restoring translation
Coyne, A. N., Yamada, S. B., Siddegowda, B. B., Estes, P. S., Zaepfel, B. L., Johannesmeyer, J., Lockwood, D. B., Pham, L. T., Hart, M. P., Cassel, J. A., et al. (2015) · Human Molecular Genetics · doi:10.1093/hmg/ddv389 · Cited by 92
Quality Control of Membraneless Organelles
Alberti, S., & Carra, S. (2018) · Journal of Molecular Biology · doi:10.1016/j.jmb.2018.05.013 · Cited by 92
Molecular Dissection of FUS Points at Synergistic Effect of Low-Complexity Domains in Toxicity
Bogaert, E., Boeynaems, S., Kato, M., Guo, L. E., Caulfield, T. R., Steyaert, J., Scheveneels, W., Wilmans, N., Haeck, W., Hersmus, N., et al. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.06.070 · Cited by 92
Rhine, K., Makurath, M. A., Liu, J., Skanchy, S., Lopez, C., Catalan, K. F., Ma, Y., Fare, C. M., Shorter, J., Ha, T., et al. (2020) · Molecular Cell · doi:10.1016/j.molcel.2020.10.014 · Cited by 92
Classification of diseases with accumulation of Tau protein
Kovács, G. G., Ghetti, B. F., & Goedert, M. (2022) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12792 · Cited by 92
Calabrese, G., Molzahn, C. M., & Mayor, T. (2022) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2022.102062 · Cited by 92
Phenotype and genotype analysis in amyotrophic lateral sclerosis with TARDBP gene mutations
Corcia, P., Valdmanis, P. N., Millecamps, S., Lionnet, C., Blasco, H., Mouzat, K., Daoud, H., Belzil, V., Morales, R. J., Pageot, N., et al. (2012) · Neurology · doi:10.1212/wnl.0b013e3182553c88 · Cited by 92
Mutational analysis of MATR3 in Taiwanese patients with amyotrophic lateral sclerosis
Lin, K., Tsai, P., Liao, Y., Chen, W., Tsai, C., Soong, B., & Lee, Y. (2015) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2015.02.008 · Cited by 91
TDP-43 Promotes Neurodegeneration by Impairing Chromatin Remodeling
Berson, A., Sartoris, A., Nativio, R., Deerlin, V. M. V., Toledo, J. B., Porta, S., Liu, S., Chung, C., Garcia, B. A., Lee, V. M. ‐., et al. (2017) · Current Biology · doi:10.1016/j.cub.2017.10.024 · Cited by 90
Role of autophagy in the pathogenesis of amyotrophic lateral sclerosis
Lee, J. K., Shin, J. H., Lee, J. E., & Choi, E.-J. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2015.08.005 · Cited by 91
Wuolikainen, A., Möritz, T., Marklund, S. L., Antti, H., & Andersen, P. M. (2011) · PLoS ONE · doi:10.1371/journal.pone.0017947 · Cited by 91
SOD1 and cognitive dysfunction in familial amyotrophic lateral sclerosis
Wicks, P. J., Abrahams, S., Papps, B., Al‐Chalabi, A., Shaw, C. E., Leigh, P. N., & Goldstein, L. H. (2009) · Journal of Neurology · doi:10.1007/s00415-009-0078-0 · Cited by 91
Self-citationMitochondrial Dysfunctions: A Red Thread across Neurodegenerative Diseases
Stanga, S., Caretto, A., Boido, M., & Vercelli, A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21103719 · Cited by 90
Quadri, M., Cossu, G., Saddi, V., Simons, E. J., Murgia, D., Melis, M., Ticca, A., Oostra, B. A., & Bonifati, V. (2011) · Neurogenetics · doi:10.1007/s10048-011-0288-3 · Cited by 90
Tudor, E. L., Galtrey, C. M., Perkinton, M. S., Lau, K., Vos, K. J. D., Mitchell, J. C., Ackerley, S., Hortobágyi, T., Vámos, E., Leigh, P. N., et al. (2010) · Neuroscience · doi:10.1016/j.neuroscience.2010.02.035 · Cited by 90
Self-citationKey Mechanisms and Potential Targets of the NLRP3 Inflammasome in Neurodegenerative Diseases
Guan, Y., & Han, F. (2020) · Frontiers in Integrative Neuroscience · doi:10.3389/fnint.2020.00037 · Cited by 90
Raffaele, S., Boccazzi, M., & Fumagalli, M. (2021) · Cells · doi:10.3390/cells10030565 · Cited by 90
Moya, G. E., Rivera, P. D., & Dittenhafer‐Reed, K. E. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22137030 · Cited by 90
Neumann, M., Valori, C. F., Ansorge, O., Kretzschmar, H. A., Muñoz, D. G., Kusaka, H., Yokota, O., Ishihara, K., Ang, L.-C., Bilbao, J. M., et al. (2012) · Acta Neuropathologica · doi:10.1007/s00401-012-1020-6 · Cited by 90
Potentiated Hsp104 variants suppress toxicity of diverse neurodegenerative disease-linked proteins
Jackrel, M. E., & Shorter, J. (2014) · Disease Models & Mechanisms · doi:10.1242/dmm.016113 · Cited by 90
Kryndushkin, D. S., Wickner, R. B., & Shewmaker, F. P. (2011) · Protein & Cell · doi:10.1007/s13238-011-1525-0 · Cited by 89
RNA as a key factor in driving or preventing self-assembly of the TAR DNA-binding protein 43
Zacco, E., Graña‐Montes, R., Martin, S. R., de Groot, N. S., Alfano, C., Tartaglia, G. G., & Pastore, A. (2019) · Journal of Molecular Biology · doi:10.1016/j.jmb.2019.01.028 · Cited by 89
DNA damage as a mechanism of neurodegeneration in ALS and a contributor to astrocyte toxicity
Kok, J. R., Palminha, N. M., Souza, C. D. S., El‐Khamisy, S. F., & Ferraiuolo, L. (2021) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-021-03872-0 · Cited by 89
The neurobiology of amyotrophic lateral sclerosis
Bento‐Abreu, A., Damme, P. V., Bosch, L. V. D., & Robberecht, W. (2010) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2010.07260.x · Cited by 89
Ingre, C., Landers, J. E., Rizik, N., Volk, A. E., Akimoto, C., Birve, A., Hübers, A., Keagle, P. J., Piotrowska, K., Press, R., et al. (2012) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2012.10.009 · Cited by 89
Identification of RNA bound to the TDP-43 ribonucleoprotein complex in the adult mouse brain
Narayanan, R. K., Mangelsdorf, M., Panwar, A., Butler, T. J., Noakes, P. G., & Wallace, R. H. (2012) · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · doi:10.3109/21678421.2012.734520 · Cited by 89
Gellera, C., Tiloca, C., Bo, R. D., Corrado, L., Pensato, V., Agostini, J., Cereda, C., Ratti, A., Castellotti, B., Corti, S. P., et al. (2012) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2012-303433 · Cited by 89
RNA-mediated toxicity in neurodegenerative disease
Belzil, V., Gendron, T. F., & Petrucelli, L. (2012) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2012.12.006 · Cited by 90
Lu, B., & Palacino, J. J. (2013) · The FASEB Journal · doi:10.1096/fj.12-219220 · Cited by 89
Recent advances in amyotrophic lateral sclerosis
Riva, N., Agosta, F., Lunetta, C., Filippi, M., & Quattrini, A. (2016) · Journal of Neurology · doi:10.1007/s00415-016-8091-6 · Cited by 89
Internalized Tau sensitizes cells to stress by promoting formation and stability of stress granules
Brunello, C. A., Yan, X., & Huttunen, H. J. (2016) · Scientific Reports · doi:10.1038/srep30498 · Cited by 89
The multifaceted role of glial cells in amyotrophic lateral sclerosis
Valori, C. F., Brambilla, L., Martorana, F., & Rossi, D. (2013) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-013-1429-7 · Cited by 88
Yu, Y., Chi, B., Xia, W., Gangopadhyay, J. P., Yamazaki, T., Winkelbauer-Hurt, M. E., Yin, S., Eliasse, Y., Adams, E., Shaw, C. E., et al. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv157 · Cited by 89
Self-citationDJ-1 in neurodegenerative diseases: Pathogenesis and clinical application
Huang, M., & Chen, S. (2021) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2021.102114 · Cited by 88
Gene Therapy in Amyotrophic Lateral Sclerosis
Fang, T., Je, G., Pacut, P., Keyhanian, K., Gao, J., & Ghasemi, M. (2022) · Cells · doi:10.3390/cells11132066 · Cited by 88
Age-Dependent TDP-43-Mediated Motor Neuron Degeneration Requires GSK3, hat-trick, and xmas-2
Sreedharan, J., Neukomm, L. J., Brown, R. H., & Freeman, M. R. (2015) · Current Biology · doi:10.1016/j.cub.2015.06.045 · Cited by 88
Self-citationDelineation of the Core Aggregation Sequences of TDP‐43 C‐Terminal Fragment
Saini, A., & Chauhan, V. S. (2011) · ChemBioChem · doi:10.1002/cbic.201100427 · Cited by 88
Full-length TDP-43 and its C-terminal fragments activate mitophagy in NSC34 cell line
Hong, K., Li, Y., Duan, W., Guo, Y., Jiang, H. X., Li, C., & Li, C. (2012) · Neuroscience Letters · doi:10.1016/j.neulet.2012.10.003 · Cited by 88
Austin, J. A., Wright, G. S. A., Watanabe, S., Grossmann, J. G., Antonyuk, S. V., Yamanaka, K., & Hasnain, S. S. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1317317111 · Cited by 88
Age of onset of amyotrophic lateral sclerosis is modulated by a locus on 1p34.1
The ALSGEN Consortium (2012) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2012.07.017 · Cited by 88
Combating deleterious phase transitions in neurodegenerative disease
Darling, A. L., & Shorter, J. (2021) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2021.118984 · Cited by 88
Sun, H., Yang, B. V., Li, Q., Zhu, X., Song, E., Liu, C., Song, Y., & Jiang, G. (2024) · Nature Nanotechnology · doi:10.1038/s41565-024-01683-5 · Cited by 87
Borroni, B., Archetti, S., Bo, R. D., Papetti, A., Buratti, E., Bonvicini, C., Agosti, C., Cosseddu, M., Turla, M., Lorenzo, D. D., et al. (2010) · Rejuvenation Research · doi:10.1089/rej.2010.1017 · Cited by 87
Self-citationBiology and Pathobiology of TDP-43 and Emergent Therapeutic StrategiesPreprint
Guo, L. E., & Shorter, J. (2016) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a024554 · Cited by 85
Allsop, D., Mayes, J., Moore, S., Masad, A. A., & Tabner, B. J. (2008) · Biochemical Society Transactions · doi:10.1042/bst0361293 · Cited by 86
Luty, A. A., Kwok, J. B., Thompson, E. M., Blumbergs, P. C., Brooks, W. S., Loy, C. T., Dobson‐Stone, C., Panegyres, P. K., Hecker, J. R., Nicholson, G. A., et al. (2008) · BMC Neurology · doi:10.1186/1471-2377-8-32 · Cited by 86
Self-citation
Metadata
- Authors
- Sreedharan, J., Blair, I. P., Tripathi, V. B., Hu, X., Vance, C., Rogelj, B., Ackerley, S., Durnall, J. C., Williams, K. L., Buratti, E., Baralle, F., de Belleroche, J., Mitchell, J. D., Leigh, P. N., Al-Chalabi, A., Miller, C. C., Nicholson, G., & Shaw, C. E.
- Affiliations
- The University of Sydney (AU)
- Department of Clinical Neuroscience, King's College London, Medical Research Council (MRC) Centre for Neurodegeneration Research, and Institute of Psychiatry, London, SE5 8AF, UK.
- Corresponding author
- Sreedharan, Jemeen
- Blair, Ian P.
- Tripathi, Vineeta B.
- Nicholson, Garth
- Shaw, Christopher E.
- ORCID
- Venue
- Science
- Published
- 2008-03-21
- Volume
- 319
- Issue
- 5870
- Pages
- 1668-1672
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- PMC
- PMC7116650
- OpenAlex
- W1619082318
- Cited by
- 2,630
- References
- 29
- Citations by year
- 2026: 73 · 2025: 88 · 2024: 104 · 2023: 141 · 2022: 149 · 2021: 141 · 2020: 149 · 2019: 121 · 2018: 147 · 2017: 117 · 2016: 156 · 2015: 154 · 2014: 167 · 2013: 168 · 2012: 192
- FWCI
- 119.36
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Figshare (submittedVersion, cc-by)
- Research Portal (King's College London) (submittedVersion)
- Sussex Research Online (University of Sussex) (submittedVersion)
- Funders
- Wellcome Trust (076671)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Amyotrophic Lateral Sclerosis Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Hereditary Neurological Disorders
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Keywords
- amyotrophic lateral sclerosis, TDP-43, TARDBP, familial ALS, sporadic ALS, TDP-43 mutations, chromosome 1p36, genetic linkage, ubiquitinated inclusions, neurodegeneration, neuronal apoptosis, protein fragmentation
- MeSH terms
- Adult, Amino Acid Sequence, Amyotrophic Lateral Sclerosis, Animals, Chick Embryo, Chromosomes, Human, Pair 1, Cricetulus, DNA-Binding Proteins, Female, Cricetinae, Humans, Male, Middle Aged, Molecular Sequence Data, Neurons, CHO Cells, Apoptosis, Microsatellite Repeats, Amino Acid Substitution, Mutation, Missense, Embryonic Development, Mutant Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
